On-line CME Discussing Multiple Myeloma

OSUWexnerbloglogo2014 On-line CME Discussing Multiple Myeloma. In the past year, there have been 4 new drugs approved to treat multiple myeloma and these are changing the way that we manage patients with this disease. On this CME webcast, we’re going to talk about what multiple myeloma is, how you diagnosis it, and how it is treated. Joining our moderator in the studio is hematologist and Assistant Professor of Internal Medicine from the OSU Wexner Medical Center, Dr. Ashley Rosko. And also from the division of hematology, we have Associate Professor of Internal Medicine, Dr. Yvonne Efebera joining us.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between MGUS, smoldering Myeloma, Symptomatic multiple Myeloma; DESCRIBE the general clinical features of plasma cell myeloma including the diagnosis, and steps required for evaluation; UNDERSTAND Treatment strategy for Newly diagnosed Multiple Myeloma Patients Eligible for Transplant and Newly diagnosed Multiple Myeloma Patients not Eligible for Transplant.

You’ll also learn about the following:

  • Epidemiology of multiple myeloma
  • Prognosis of multiple myeloma
  • When to do a bone marrow biopsy?
  • Screening patients with kidney failure for multiple myeloma
  • Management of hypercalcemia and renal failure in multiple myeloma
  • Autologous versus allogenic stem cell transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Educates Physicians on Kidney Stones

OSUWexnerbloglogo2014 CME Webcast Educates Physicians on Kidney Stones. The Dornier lithotripsy machine was first used in 1980 to break apart kidney stones using an acoustic pulse. In the 36 years since then, shock wave lithotripsy has become a primary tool for urologists to treat kidney stones. But when is it the right way to treat kidney stones? And how do you evaluate patients with a kidney stone in order to devise treatment strategies to keep them from having a second one? On this CME webcast, we’re going to be examining these questions. Joining us, to tell us about the diagnosis and treatment of kidney stones is Associate Professor of Urology, Dr. Bodo Knudsen. Then, to tell us about the medical evaluation of patients with kidneys stones and the prevention of recurrent stones, we have Nephrologist and Associate Professor of Internal Medicine, Dr. Ganesh Shidham.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS types of kidney stones; IDENTIFY risk factors for kidney stone and discuss etiology of these risk factors; DISCUSS medical management for prevention of kidney stones; DESCRIBE the prevalence of kidney stones in the United States; EXPLAIN the surgical options for lower pole kidney stones > 1.0 cm.

You’ll also learn about the following:

  • Common signs and symptoms of kidney stones
  • Risk factors for kidney stones
  • Initial diagnostic test in the emergency department
  • Which patients require admission to the hospital
  • When to do stone chemical analysis
  • Approach to the incidentally diagnosed kidney stone
  • Kidney stones in children
  • Shock wave lithotripsy technique
  • Stents for kidney stones
  • When to refer
  • The role of the dietician

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as a hospital network. You can also e-mail him at derrick.freeman@osumc.edu.